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Abstract
Background: We sought to develop a more reliable structured implicit chart review instrument
for use in assessing the quality of care for chronic disease and to examine if ratings are more reliable
for conditions in which the evidence base for practice is more developed.
Methods: We conducted a reliability study in a cohort with patient records including both
outpatient and inpatient care as the objects of measurement. We developed a structured implicit
review instrument to assess the quality of care over one year of treatment. 12 reviewers conducted
a total of 496 reviews of 70 patient records selected from 26 VA clinical sites in two regions of the
country. Each patient had between one and four conditions specified as having a highly developed
evidence base (diabetes and hypertension) or a less developed evidence base (chronic obstructive
pulmonary disease or a collection of acute conditions). Multilevel analysis that accounts for the
nested and cross-classified structure of the data was used to estimate the signal and noise
components of the measurement of quality and the reliability of implicit review.
Results: For COPD and a collection of acute conditions the reliability of a single physician review
was quite low (intra-class correlation = 0.16–0.26) but comparable to most previously published
estimates for the use of this method in inpatient settings. However, for diabetes and hypertension
the reliability is significantly higher at 0.46. The higher reliability is a result of the reviewers
collectively being able to distinguish more differences in the quality of care between patients (p <
0.007) and not due to less random noise or individual reviewer bias in the measurement. For these
conditions the level of true quality (i.e. the rating of quality of care that would result from the full
population of physician reviewers reviewing a record) varied from poor to good across patients.
Conclusions:  For conditions with a well-developed quality of care evidence base, such as
hypertension and diabetes, a single structured implicit review to assess the quality of care over a
period of time is moderately reliable. This method could be a reasonable complement or
alternative to explicit indicator approaches for assessing and comparing quality of care. Structured
implicit review, like explicit quality measures, must be used more cautiously for illnesses for which
the evidence base is less well developed, such as COPD and acute, short-course illnesses.
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Background
Assessing the quality of health care for populations of
patients over time is a major challenge facing health sys-
tems and health insurers [1,2]. Increasingly, quality meas-
urement for such populations focuses on chronic illnesses
and is carried out using explicit, or pre-set, review criteria
or indicators. The widely used indicators approach to
quality assessment (e.g., Health Plan Employer Data and
Information Set HEDIS 2000) addresses chronic disease
management for an ever-growing number of chronic dis-
eases such as hypertension, diabetes, and depression [3].
For a variety of reasons, however, explicit indicators have
not entirely replaced the other principle method for
assessing quality of care, implicit peer review, throughout
the healthcare, regulatory and legal system.
Implicit peer review relies on expert judgment of the qual-
ity of care for an individual patient case. In its most rigor-
ous implementation, structured implicit review (SIR) has
been an important tool for measuring quality of care in
research [4-13]. Implicit review, as carried out by Medi-
care Peer Review Organizations, was widely used to try to
prevent abuse arising from application of prospective pay-
ment for hospitals [14]. While Medicare and the Peer
Review Organizations have increasingly emphasized
explicit process measures over implicit record review by
physicians [15,16], there is still nearly universal use of
implicit review by hospitals and physician groups in cre-
dentialing and determining clinical privileges [17,18]. A
form of implicit peer review by expert physicians is the
only method of assessing standard of care consistently
used in malpractice litigation.
The continued use of implicit review is most likely due to
the ease of development and administration of the
method, its face validity, and its ability to self-update
through use of current experts, to reflect the full scope of
clinical decisions that may apply to a particular patient,
and to involve physicians in the quality of care process.
These are areas in which explicit indicators such as HEDIS
can be criticized for falling short. Of concern, however, is
the well-documented low reliability of peer review meth-
ods, particularly those that are unstructured, and the lack
of testing of the method for review in the outpatient set-
ting, where the majority of care is delivered for chronic
illnesses.
The estimated reliability for the measurement of overall
quality of care in the published literature, even when
using SIR, is generally poor, in the range of 0.2 to 0.3
[6,9,12,13,19,20] with two studies citing reliability of 0.5
[5,7]. Even more variable estimates of reliability are
obtained for rating specific components of care or other
settings of care [10,11,21,22]. One source of variation in
reliability estimates is the numerous methods employed
for quantifying reliability. Most studies of implicit review
report simple kappa statistics or correlations and none
consider the cross-classified nature of the data (a review is
nested within patients crossed with reviewer). Most ignore
the tendency for some reviewers to consistently judge
more harshly or leniently than other reviewers. When
studies do consider these reviewer effects, they estimate
them in a way that does not readily allow the reliability
findings to be generalizable to other reviewer populations
(by using fixed instead of random effects in the analysis)
[23,24]. Finally, few published reliability studies examine
how reliability is affected by diagnosis or care delivered
over an extended period of time. Understanding the con-
ditions under which implicit review functions well may be
critical to improving the capabilities and use of the
method.
This study evaluates structured implicit review of outpa-
tient and inpatient care over a one year period for a pop-
ulation of patients by evaluating care for three chronic
illnesses and for rapid onset, short course acute illnesses.
We developed a new structured implicit review instru-
ment drawing on previously tested instruments [5,10,20].
We selected reviewers well versed in evidence based prin-
ciples of practice and trained them to emphasize evi-
dence-based care in their reviews. We addressed
limitations of previous studies in two ways. First we tested
the effects on implicit review of the quantity and quality
of the evidence base for a condition by comparing review
reliability for two conditions (diabetes, hypertension) for
which the quality of care evidence base is substantial to
two others for which it is limited (COPD, acute illnesses).
Second we evaluated the relative importance of several
sources of variability in implicit reviews using generaliza-
bility theory (an extension of classical test theory) [25].
With these techniques, extraneous sources of variation can
be identified and potentially removed, leading to signifi-
cant improvement in the measurement properties of
implicit review.
Methods
Study sample and data collection
As part of a larger study, we sampled veterans who had at
least two outpatient visits for each of two years in clinics
offering primary care from eleven health systems in two
regions, one in the Midwest and one in the West. We over
sampled three target conditions (diabetes, hypertension,
and COPD). We requested medical records for each
patient for a two-year time period from October 1, 1997
to September 30, 1999. For this study, we selected 70 cases
from the full sample of 621 cases selected for the larger
study using stratified random sampling, oversampling for
the three target chronic disease conditions. Reviewers
then used implicit review to evaluate care given over aBMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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thirteen-month period: September 1, 1998 to September
30, 1999.
Reviewer selection and training
Selection of reviewers
Reviewers were required to be trained, board certified
internists (American Board of Internal Medicine) with
current or recent general or internal medicine outpatient
experience and to be conversant with principles of evi-
dence-based medicine. This latter qualification was
assessed through the use of a screening questionnaire and
discussions with one or more clinicians listed as refer-
ences by the applicants for the reviewer positions [see
Additional file 1]. All were one or more years beyond res-
idency. Although primarily in academic positions, they
worked in a variety of practice settings and two different
geographic locations. They were solicited by flyer, email
and word of mouth. Only one had previously done qual-
ity related record reviews and none was a professional
reviewer.
Description of the training
Each reviewer completed sixteen hours of training. The
reviewers were instructed to imagine that, for each case
reviewed, the patient was a new patient in their practice
and coming with the documentation of the last 1–2 years
of their care. For each of the conditions they were asked to
assess the diagnosis and assessment of the initial presen-
tation of the condition (if it occurred during this period),
assessment and monitoring the course of the condition,
treatment of signs or symptoms, exacerbations or compli-
cations, and follow-up. They were then asked to provide
an assessment of the quality of care. In providing this
assessment they were to consider how the care compares
to what would be provided in a typical US community
practice with respect to appropriateness, timeliness and
quantity. In particular was the care appropriate, or was
there overuse, misuse, or underuse? They were further to
consider the importance of any overuse, underuse, or mis-
use. That is, if care was not completely appropriate, they
were asked to consider whether the problems were likely
to result in worse outcomes for a typical patient with the
medical problem. They were instructed to focus on the
process of care, and links supporting causal connections
between processes and outcomes, and not the outcomes
themselves. Then they rated the overall quality of care on
a six-point scale.
Review process
Reviews took place in Ann Arbor and Los Angeles over a 6
month period from October 2001 to March 2002. The
reliability sub-study took part within the larger job of
reviewing the 621 charts from the parent study. Reviewers
were unaware of which records were chosen for the relia-
bility analyses. During the review, reviewers were able to
scan available records prior to the study period (October
1, 1997 to August 31, 1998), but were instructed that their
review should focus on care provided during the study
period.
Design
Table 1: Mean ratings and distribution of reviews across conditions
Reviewer HTN‡ COPD§ Diabetes Acute Care Total Mean rating (s.d)
A 11 9 8 12 40 3.28 (1.11)
B 1 51 2 8 1 04 5 3 . 1 3  ( 1 . 2 0 )
C 14 7 9 11 41 3.15 (1.37)
D 13 9 9 12 43 3.58 (1.61)
E 11 9 7 12 39 3.33 (0.58)
F 12 8 11 10 41 2.24 (1.18)
G 10 8 9 9 36 3.78 (1.29)
H 10 8 8 8 34 3.15 (0.93)
I 1 41 01 2 6 4 2 3 . 2 6  ( 0 . 9 1 )
J 1 71 0 9 1 75 3 3 . 4 0  ( 0 . 7 7 )
K 12 8 8 9 37 3.38 (0.59)
L 14 7 9 15 45 3.29 (1.38)
Total 153 105 107 131 496
# unique records † 56 40 37 59 70
Mean rating (s.d)* 3.46(1.20) 3.09(0.96) 3.46(1.30) 2.94(1.07) 3.25 (1.16)
*Ratings are on a 1–6 scale where 1 = very good care and 6=very poor care. † Each patient record may have been reviewed for more than one 
condition. Thus 56 out of the 70 total records were reviewed for the quality of hypertension care. A total of 153 reviews of the 56 different patient 
records were done by 12 different reviewers. ‡ Hypertension § Chronic obstructive pulmonary diseaseBMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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The reliability study consisted of 12 physicians reviewing
70 patient records. Each patient record may have been
reviewed for more than one condition. For example, 56
out of the 70 total records were reviewed for the quality of
hypertension care and 59 were reviewed for acute care. For
each patient record, three out of the 12 physician review-
ers filled out between one and four condition specific
instruments giving a total of 496 reviews over the whole
sample. Assignment of reviewers to cases was random but
stratified to balance each reviewer's appearance across the
conditions and condition combinations. Three different
reviewers reviewed each of the 70 cases. Table 1 shows the
distribution of patients, conditions and reviews.
Data analysis
Our one pre-specified hypothesis was that the reliability
of physician review, as measured by the intraclass correla-
tions, would be significantly larger for the hypertension
and diabetes quality ratings than for the COPD and acute
conditions. Our model simultaneously examines reliabil-
ity across the four separate domains of hypertension,
COPD, diabetes and acute care management in a
MANOVA style analysis. The model also accounts for the
clustering of multiple reviews and multiple conditions
within patient and the fact that each reviewer reviewed
overlapping subsets of the 70 patients. We used a cross-
classified, random effects model implemented in MLwiN.
This analysis assumes that the rating data are normally
distributed which appears warranted by the distribution
plots illustrated in Figure 1. Details of the estimation
method and model selection are described in the
Appendix.
The analysis provides us with the variability of the true
quality rating across patients, the variability in how each
reviewer rates quality and the variability contributed by
the undifferentiated noise in the measurement. The intra-
class correlation (ICC) we report is the variability of the
true quality rating divided by the total variability in the
ratings (or the sum of all three sources of variability). The
ICC can be interpreted as the proportion of variance that
is due to the true differences in quality across patients.
However, it is also the correlation between ratings that
would be expected when two random reviewers rate the
same record, and thus, it describes the reliability of a sin-
gle review by a single randomly selected reviewer. (see the
appendix for further details about calculating ICCs).
Results
Distribution of reviews and mean ratings
The distribution of reviews across conditions and review-
ers is shown in Table 1. Reviewers were represented fairly
evenly across conditions, reviewing between 7 and 17
cases each. There was considerable overlap of conditions
across patients with most records being evaluated for
more than 1 condition. 12 records were evaluated for all
four conditions, 31 records had three conditions, 24
records had 2 conditions and 3 records had only one of
the four conditions. Thus while there are 70 total unique
records, for each condition there are between 37 and 59
unique records that were reviewed.
The mean overall rating was 3.25 on a 1 to 6 scale, with a
score of 1 assigned for very good care and a score of 6
assigned for very poor care. The reviewers used the entire
six point scale given, with the distribution of ratings by
condition shown in Figure 1. Table 1 also suggests differ-
ences in the mean ratings by reviewer and by condition.
Regression model
The results of the analysis using the full model are shown
in Table 2. Variation at the patient level represents the true
score differences in physician assessed quality of care
across patient records in regard to the management of a
particular condition. The true score is the rating that
would be obtained from an infinitely large number of
reviews and reviewers who were drawn from the popula-
tion represented by our sample of reviewers. Variation at
the reviewer level represents the idiosyncratic differences
in opinions between physician reviewers and the extent to
which some reviewers may have systematically higher or
lower ratings than other reviewers across all records for a
given condition. Variation at the review occasion level
(repeated measurements of the same record) is termed
"noise." It can be thought of as a reflection of the difficulty
of the evaluation task. If it is hard to say whether the care
provided is good or not, then there will be more noise.
The relative size of the variance components for the true
score, reviewer and noise are shown graphically in Figure
2.
We found that the true score variation (variance) in qual-
ity of care at the patient level for hypertension was 0.75
(thus the true score standard deviation is   = 0.87,
see Table 2). Consequently, we would predict that if
reviewer ratings were averaged over a large population of
reviewers similar to ours, 95% of the ratings would fall
within 1.7 units (two standard deviations) in either direc-
tion of the average rating of 3.4 found for hypertension.
That represents a range that is between poor and good and
provides evidence that, even after accounting for the
measurement error of this instrument, there are important
differences in the quality of hypertension care. There is a
comparable amount of variation due to noise (0.72) and
a relatively small amount of variation due to systematic
differences across patients by reviewer in their assessment
of quality (0.15) indicating good agreement in the stand-
ards applied by the reviewers. The reliability of a single
review for detecting differences in quality of hypertension
care across patients is 0.46. Averaging as few as 5 reviews
07 5 .BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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of a single patient record would allow you to produce a
rating of the quality of hypertension management for that
patient with a reliability of 0.80, a level generally felt to be
adequate for making decisions based on a measure [26].
The diabetes care evaluation works in very similar ways to
the hypertension one discussed above (Table 2).
On the other hand, the structured implicit review of
COPD care produced a true quality rating with a smaller
variance of 0.30 (s.d. .55). This implies that 95% of
patients with this condition experience care whose quality
is rated between good and borderline. When the range of
quality is narrow it becomes less clinically interesting to
try to search for reasons for the differences in quality
across patients or to profile providers. While the noise
component is also smaller when compared to the hyper-
tension ratings, implying that the evaluation problem is
not inherently more difficult, it shrank less than the true
quality differences. Thus the reliability of a single review
(true score variance over the total variance) is much
smaller at 0.26 and over twice as many reviews would be
required to generate a reliable quality measure for the
management of COPD for a patient (12 reviews for a reli-
ability of 0.80).
Distribution of quality ratings by condition Figure 1
Distribution of quality ratings by condition This figure illustrates the distribution of ratings by condition for all the 
reviews done for that condition. Thus there are multiple observations per patient. The fact that ratings are clustered by 
reviewer and patient is not accounted for in this figure. The entire scale was used for each condition. A normal density for the 
observed mean and standard deviation is superimposed on the histogram of the actual distribution of ratings. The conditions 
are hypertension (HTN), diabetes, chronic obstructive pulmonary disease (COPD), and acute conditions.
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There is also less detectable systematic difference in the
true quality of acute care management across patients
(variance 0.26) than for diabetes or hypertension. In addi-
tion there is a substantially larger amount of random
noise (1.03). Overall, the reliability of a single review is
0.16 making the instrument much less practical for the
purpose of estimating the quality of care in a panel of
patients (requiring 30 reviews to achieve a reliability of
0.80). Furthermore, the idiosyncratic evaluations of acute
care management of the individual reviewers vary more
widely (reviewer variance = 0.33) than the aspects of acute
care management that they can agree upon (true score
patient variance = 0.26).
The estimation techniques we used allowed us to produce
an empirical confidence interval for the reliability of each
instrument (shown in Figure 3). As per our primary
hypothesis, the hypertension and diabetes instruments
taken together were significantly more reliable than the
COPD and acute care instruments as shown by the non-
overlapping confidence intervals. Furthermore, the
patient level variance components for diabetes and hyper-
tension were significantly larger than those for COPD and
Variance components of medical record review Figure 2
Variance components of medical record review The sources of variability in physician assessments of quality of care 
based on reviews of the medical record are shown here, stratified by the levels of evidence available for decision-making. The 
much larger amounts of signal or true quality differences in reviews of the high evidence conditions will produce measurements 
that are more reliable. For the low evidence conditions, the noise component is quite large for the reviews of acute conditions 
and the reviewer components are relatively large for both the acute and COPD conditions. The conditions are hypertension 
(HTN), diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), and acute conditions.
Conditions
0 .5 1 1.5 2
Variance in quality of care rating
Low evidence
High evidence
COPD
ACUTE
HTN
DM
Random Design factor
Noise Reviewer severity
Quality differencesBMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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acute conditions (Wald chi squared test 3.62, p < 0.007)
suggesting that the improved reliability is largely a result
of the reviewers being able to distinguish a greater
difference in the quality of care across the diabetes and
hypertension patients.
The correlations between the ratings of quality of disease
management are also shown in Table 2. The patient rat-
ings of diabetes and hypertension are correlated fairly
highly at 0.77 as might be expected given that there is con-
siderable overlap in the indicated processes of care for the
two conditions. The correlations between all other pairs of
ratings are in the low to modest range 0.11–0.38, indicat-
ing that there is different information about disease man-
agement that is being evaluated for the different disease
management domains. These correlations are corrected
for any attenuation that would occur due to the measure-
ment error in the instruments and represent the correla-
tions between the 'true' ratings (as defined above).
Discussion
There are a number of important conclusions that one can
draw from this work. First, we have shown that using
structured implicit review it is possible to obtain ratings of
the management of chronic diseases over an extended
period of time and settings of care and that these ratings
can have reasonably high reliability. Second, as we
hypothesized, those conditions for which the evidence
base is most developed, diabetes and hypertension, were
the ones in which we were able to achieve the highest lev-
els of reliability. Third, the analytic approach that we
espouse offers an important advance in assessing quality
measurement tools by allowing us to draw substantive
conclusions about how and for which conditions to
attempt to measure quality of care using structured
implicit review.
Using structured implicit review for evaluation of the 
continuum of care
Most physician peer review is done in hospitalized
patients. While there is a recent RAND publication
describing an outpatient implicit review instrument [27],
there are no peer-reviewed published reliability studies of
instruments used outside of the hospital setting and no
structured implicit review instruments designed to meas-
ure quality across the continuum of care (over time and
including inpatient and outpatient care). Yet to measure
chronic disease care in particular, with its long-term objec-
tives and multiple providers, this is the frame of interest.
For diabetes and hypertension, we achieved reliability
measures that are as high as any published and that reflect
an instrument that could produce a reliable estimate of
the quality of disease management for a particular patient
with as few as 5 record reviews. It is important to remem-
ber that the reliability of an instrument for distinguishing
between patients does not tell us the reliability of using
average scores across patients to distinguish between sites
or physicians [28]. While we know that patient satisfac-
tion and a number of individual quality measures have
Table 2: Sources of variation and reliability of quality assessments by physician implicit review
HTN COPD Diabetes Acute
Mean rating (1 – 6) * 3.41 3.09 3.39 2.90
Variance §
Reviewer 0.15 0.34 0.34 0.33
Patient (between record) 0.75 0.30 0.88 0.26
Noise (within record) 0.72 0.50 0.69 1.03
Total variance 1.62 1.14 1.90 1.62
Proportion of total variance †
Reviewer‡ 0.09 0.30 0.18 0.20
Patient (between record) 0.46 0.26 0.46 0.16
Noise (within record) 0.44 0.44 0.36 0.64
Correlation of quality ratings at patient level
COPD 0.382
Diabetes 0.767 0.106
Acute 0.359 0.314 0.262
*Ratings are on a 1–6 scale where 1 = very good care and 6=very poor care. This is the rating for the average patient accounting for differences in 
reviewer severity. † Other than rounding error, the proportion of total variance sums to 100 across the 3 components. ‡ The proportion of 
variance at the patient level represents the reliability of structured implicit review for detecting differences between patients when assessed for 
samples of patients from a similar population and assessed by reviewers drawn from a population of similar reviewers. § Variation at the patient level 
represents the true score differences in physician ratings of quality of care across patients in regard to the specified condition. Variation at the 
reviewer level represents the idiosyncratic differences in rating severity the between physician reviewers. Variation at the review occasion level 
(repeated measurements of the same record) is termed "noise."BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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quite low reliabilities at the physician level [28-30], no
study has reported a reliability for the use of the structured
implicit review instrument in physician profiling. To esti-
mate how many patients would be required to produce
reliable physician or site quality estimates, we would need
to assess the variability across another dimension, the site
of care or the provider.
Nevertheless, we can say that if the true differences
between physicians or sites of care, averaged across their
patients, are on the same order as that seen across patients
in this study (that is ranging from poor to good), then a
relatively small sample of 5–10 reviews would be suffi-
cient to characterize the care for that site of care for condi-
tions with a good evidence base for practice. Of course if
the range of average ratings for physicians or sites of care
is much smaller (e.g. clustered around "adequate-good"
care) then the reliability for distinguishing between sites
of care or providers will be much less, and a larger sample
would be required. However, if all of the care is at a simi-
lar level across sites, then distinguishing between them
becomes much less important [28].
Reliability of a single physician review of a patient record for detecting quality differences Figure 3
Reliability of a single physician review of a patient record for detecting quality differences This figure presents the 
reliability (intraclass correlation coefficients) of a single implicit review for detecting differences in true quality across patients. 
At the top, the conditions with a more developed or high evidence base (diabetes and hypertension) are compared to those 
with a less developed or low evidence base (COPD and acute conditions). At the bottom, the reliability for each of four condi-
tions is presented with the empirical 95% confidence interval limits. The conditions are hypertension (HTN), diabetes mellitus 
(DM), chronic obstructive pulmonary disease (COPD), and acute conditions.
Levels of evidence
Condition
Acute
COPD
DM
HTN
High Evidence
Low Evidence
 
0 .25 .5 .75 1
Reliability
(Intra−class correlation coefficient)BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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While it is somewhat paradoxical that the reliability of a
quality measure decreases as care increasingly conforms to
a similar standard, it makes perfect sense that it is harder
to distinguish small differences between providers or
patients than it is to distinguish large differences. In fact
this is extremely useful information to have. It can tell the
profilers when they should describe the quality of care by
the overall mean rather than bothering to generate pro-
vider specific measures.
When we consider the cost and difficulty of implementing
explicit indicator approaches to quality assessment
[31,32], implicit review instruments with this level of reli-
ability become an interesting alternative for assessing
quality of care for the purposes of comparing across pro-
viders or sites of care.
Increased evidence base improves the consistency of 
evaluation
Apart from coronary artery disease, diabetes and hyper-
tension are two of the diseases with the largest number of
published randomized clinical trials supporting the use of
specific interventions to reduce significant the mortality
and morbidity associated with these conditions. A
Medline search with the condition as major heading
restricted to randomized controlled trials and no date
restriction, reveals 2028 and 5275 randomized controlled
trials within diabetes and hypertension respectively and
65 for COPD. Thus it is intriguing that the instruments
measuring the quality of care for these conditions had the
highest reliability while the COPD instrument had a
lower reliability, reflecting a smaller component of vari-
ance attributable to differences in quality perceived sys-
tematically across all the reviewers.
It should not be surprising that physician implicit review
works best for those conditions where the evidence base is
best developed, just as these are the areas where explicit
checklist forms of quality measurement are easiest to
develop. Implicit physician review would have been a par-
ticularly useful tool if it could fill in the gap for assessment
of conditions where the evidence base is less well devel-
oped, however, our study does not support this use. Even
so, there may well be settings where implicit review is a
more feasible approach than explicit measures and it
might be desirable to use a combination of explicit and
implicit methods, as they are complementary in many of
their strengths and weaknesses. Furthermore, if a suitable
sample of physician reviewers is selected, this type of reli-
ability study can quantify the degree of uncertainty that
exists among expert physicians about the standards of care
for a particular disease management area. It can be very
useful to know that we should not attempt to profile care
for a condition because even a group of experts does not
have a very clear or consistent sense of whether care was
appropriate in any given situation.
An analytic framework for evaluating quality 
measurement instruments
Generalizability theory is an appealing theoretical frame-
work to use when trying to define and improve the meas-
urement characteristics of an instrument [25]. Using the
techniques employed here for partitioning the source of
variability in ratings of quality of care, investigators have
previously examined whether discussion of a case
between reviewers can improve the reliability of struc-
tured implicit reviews. They found that it only provided a
mirage of increased agreement, without any improvement
in the reliability of the true score ratings [33]. Another
study that evaluated quality of care at community based
care organizations for the elderly (PACE centers) with a
modified structured implicit review instrument, was the
first to assess the contribution of different sources of vari-
ation to the measurement of quality by physician review.
However, there were only 6 physician reviewers, hospital
records were excluded and the instrument failed to
identify any systematic variation in overall quality across
patients (reliability of 0) for physician reviews [10].
Using this analytic approach, we found the most interest-
ing differences across conditions are in the variance com-
ponents that estimate the true quality differences found
across patients and the difficulty of the review task (or
noise component, see Figure 2). As is suggested by the rel-
atively small differences in the quality component
between patients for COPD, it may well be that the poor
reliability of peer review in some settings is simply the
result of the lack of information on which to base system-
atic practice. In other cases, as suggested by our results for
the acute care instrument, the decision task seems partic-
ularly difficult, as reflected by the larger noise component.
A better definition of the condition to be assessed or better
training techniques might be able to reduce this compo-
nent and improve the reliability of the instrument.
With the information generated by this type of analysis it
is possible to define the optimal number of patients per
provider or site and the number of reviews per patient
necessary to produce a reliable measure for the level of
comparison (provider or site) that is desired. While not
commonly done, it is certainly possible to have more than
one physician reviewer per record in an operational qual-
ity measurement system that sampled records from sites
to monitor quality of care using implicit review. It is the
possibility of designing more efficient measurement pro-
cedures that is the greatest potential contribution of this
approach.BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
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Conclusions
For evaluation of diabetes or hypertension care, a struc-
tured implicit review instrument would seem to be a via-
ble alternative or complement to explicit indicator
methods of assessing quality of care. There may be many
cases where this may be a less expensive method to use,
particularly where explicit indicator measures require
extensive information technology modifications. The
degree to which implicit review is more comprehensive
and able to take into account the subtleties of care may
make it more palatable to physicians. It may provide a
counterweight to the tendency to teach to the test with
specific indicator approaches [31]. Together, where the
two methods are correlated, an assessment might be able
to both reflect the individual nature of health care
through implicit peer judgments and provide information
about specific failed processes of care from an explicit
indicator approach. It may be time to use structured
implicit review more widely outside of research settings to
assess quality of care.
Appendix
Estimation of the parameters was carried out by Bayesian
methods, specifically a Markov Chain Monte Carlo
(MCMC) method (MLwiN version 1.2). We specified
non-informative priors and chain length was set to
500,000, sampling one out of every twenty iterations to
minimize autocorrelation. In all models this was enough
to reduce the Monte Carlo simulation error so that the
estimate of each variance component was accurate to
within 2 significant figures and the 95% coverage estimate
was within 1% of the nominal 95% coverage interval [34].
The full model design has review occasion clustered by
patient record, cross-classified with reviewer. Estimated
parameters include a constant representing the mean rat-
ing; as well as variance estimates for the reviewer, patient
record and review occasion for each of the four domains
(hypertension, diabetes, COPD and acute care manage-
ment). Model fit was estimated by examining the DIC
(deviance information criterion) and the patterns of
residuals.
The DIC was 2383 for the full model. However, the pat-
tern of residuals at the reviewer level (and indeed the mar-
ginal ratings shown in Table 1) suggested that reviewer F
was a potential outlier having the lowest score in three of
the four domains. Thus a model was fit with the ratings of
reviewer F estimated as a fixed effect. The DIC was 2425
representing worse fit. However, more importantly, the
relative magnitude of the patient record variation and the
noise variation was unchanged. Thus all results are pre-
sented for the full model.
Calculating reliability with an ICC
Several ICCs or reliabilities can be calculated when using
this type of analysis. First, the most useful measure when
considering the use of this instrument in other settings is
the correlation of ratings between reviews of the same
patient by two randomly selected reviewers and is calcu-
lated as
σ2
patient/(σ2
patient+σ2
reviewer+σ2
noise).   (Eq. 1)
The correlation between reviews of the same patient by
the same reviewer is
(σ2
patient+σ2
reviewer)/(σ2
patient+σ2
reviewer+σ2
noise)   (Eq. 2)
and is naturally higher, and is analogous to running all
your measurements with the same instrument to reduce
measurement error. However it does not reflect a particu-
larly useful measurement strategy (one reviewer can not
review all records). If an entity wished to use this instru-
ment and was able to do a similar analysis to this current
one for its sample of reviewers, it could estimate and
remove their specific reviewer effects (which are extrane-
ous noise to the primary purpose of detecting patient dif-
ferences) and improve the reliability of the measurement.
In this case, without the reviewer variation, the reliability
is
σ2
patient/(σ2
patient+σ2
noise).   (Eq. 3)
We report reliability based on Eq. 1 described above but
this method of analysis allows one to compute whichever
reliability measure is appropriate for a particular set of
measurement conditions.
A much more commonly used measure of reliability in
this setting is the kappa coefficient. In the case of two
reviewers this data could be analysed for agreement of the
1–6 score assigned by each reviewer. The weighted kappa
is mathematically equivalent to the ICC as calculated by
equation 3 in the case of two raters when the weight is1-
{(i-j)/(k-1)}2 (where i and j index the ratings by the two
raters and k is the number of categories) [35]. The ICC
analysis can accommodate the more complex designs
commonly used in these reliability studies and provides a
much richer description by identifying the various contri-
butions to the lack of agreement.
Competing interests
None declared.
Authors' contributions
TPH drafted the manuscript, performed the statistical
analysis and participated in the design. SMA conceived of
the study, and participated in its design, analysis and coor-BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
Page 11 of 12
(page number not for citation purposes)
dination. RAH participated in the design, analysis and
manuscript preparation. LVR participated in the design,
and manuscript preparation. MMH supervised the data
collection and data management, and participated in the
design, coordination and analysis. JA participated in the
design and statistical analysis. EAK conceived of the study,
and participated in its design, analysis and coordination
Additional material
Acknowledgements
The work was supported by VA HSRD IIR #98–103: Evaluating the per-
formance of explicit quality monitoring systems in the VHA. Drs. Kerr & 
Asch are supported by Career Development Awards from the Health Serv-
ices Research and Development Office of the Department of Veterans 
Affairs. Additional support was provided by the National Institute of Health 
(NIDDK P60-972573).
References
1. Chronic Disease in Adults  [http://www.ahrq.gov/news/focus/
chadult.htm]. AHRQ Focus on Research. AHRQ Publication No. 02-
M026, March 2002. Agency for Healthcare Research and Quality,
Rockville, MD
2. Coye MJ: No Toyotas in health care: why medical care has not
evolved to meet patients' needs.  Health Aff (Millwood) 2001,
20(6):44-56.
3. National Committee for Quality Assurance: HEDIS 2000 Washington
DC.: NCQA; 1999. 
4. Rubin HR, Kahn KL, Rubenstein LV, Sherwood MJ: Guidelines for Stuc-
tured Implicit Review of the Quality of Hospital Care for Diverse Medical
and surgical Complications Santa Monica, CA: RAND Corporation;
1990. 
5. Rubenstein LV, Kahn KL, Reinisch EJ, Sherwood MJ, Rogers WH,
Kamberg C, Draper D, Brook RH: Changes in quality of care for
five diseases measured by implicit review, 1981 to 1986. JAMA
1990, 264(15):1974-9.
6. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers
AG, Newhouse JP, Weiler PC, Hiatt HH: Incidence of adverse
events and negligence in hospitalized patients. Results of the
Harvard Medical Practice Study I.  N Engl J Med 1991,
324(6):370-6.
7. Rubin HR, Rogers WH, Kahn KL, Rubenstein LV, Brook RH: Watch-
ing the doctor-watchers. How well do peer review organiza-
tion methods detect hospital care quality problems? JAMA
1992, 267(17):2349-54.
8. Hayward RA, Bernard AM, Rosevear JS, Anderson JE, McMahon LF Jr:
An evaluation of generic screens for poor quality of hospital
care on a general medicine service [see comments]. Med Care
1993, 31(5):394-402.
9. Localio AR, Weaver SL, Landis JR, Lawthers AG, Brenhan TA, Hebert
L, Sharp TJ: Identifying adverse events caused by medical care:
degree of physician agreement in a retrospective chart
review. Ann Intern Med 1996, 125(6):457-64.
10. Smith MA, Atherly AJ, Kane RL, Pacala JT: Peer review of the qual-
ity of care. Reliability and sources of variability for outcome
and process assessments. JAMA 1997, 278(19):1573-8.
11. Ashton CM, Kuykendall DH, Johnson ML, Wray NP: An empirical
assessment of the validity of explicit and implicit process-of-
care criteria for quality assessment.  Med Care 1999,
37(8):798-808.
12. Hayward RA, Hofer TP: Estimating hospital deaths due to med-
ical errors: preventability is in the eye of the reviewer. JAMA
2001, 286(4):415-20.
13. Thomas EJ, Studdert DM, Brennan TA: The reliability of medical
record review for estimating adverse event rates. Ann Intern
Med 2002, 136(11):812-6.
14. Kosecoff J, Kahn KL, Rogers WH, Reinisch EJ, Sherwood MJ, Ruben-
stein LV, Draper D, Roth CP, Chew C, Brook RH: Prospective pay-
ment system and impairment at discharge. The 'quicker-
and-sicker' story revisited. JAMA 1990, 264(15):1980-3.
15. Jencks SF, Cuerdon T, Burwen DR, Fleming B, Houck PM, Kussmaul
AE, Nilasena DS, Ordin DL, Arday DR: Quality of medical care
delivered to Medicare beneficiaries: A profile at state and
national levels. JAMA 2000, 284(13):1670-6.
16. Conditions of Participation (CoPs), Conditions for Coverage (CfCs), Quality
Improvement System for Managed Care (QISMC), Year 2000 Standards
and Guidelines  [http://www.cms.hhs.gov/cop/2d1.asp]. Centers for
Medicare and Medicaid Services, Washington DC 2000 Jul 26
17. Lindrooth RC, Calhoun EA, Welshman EE, Budetti PP: Peer Review
at Teaching Hospitals: Results from a National Survey. Journal
of Quality Health Care 2002, 1(2):16-9.
18. Sifner TA: Establishing a Peer Review Process. Journal of Quality
Health Care 2002, 1(2):31-2.
19. Goldman RL: The reliability of peer assessments of quality of
care. JAMA 1992, 267(7):958-60.
20. Hayward RA, McMahon LF Jr, Bernard AM: Evaluating the care of
general medicine inpatients: how good is implicit review? Ann
Intern Med 1993, 118(7):550-6.
21. Pearson ML, Lee JL, Chang BL, Elliott M, Kahn KL, Rubenstein LV:
Structured implicit review: a new method for monitoring
nursing care quality. Med Care 2000, 38(11):1074-91.
22. Chang BL, Lee JL, Pearson ML, Kahn KL, Elliott MN, Rubenstein LL:
Evaluating quality of nursing care: the gap between theory
and practice. J Nurs Adm 2002, 32(7–8):405-18.
23. Bravo G, Potvin L: Estimating the reliability of continuous
measures with Cronbach's alpha or the intraclass correla-
tion coefficient: toward the integration of two traditions. J
Clin Epidemiol 1991, 44(4–5):381-90.
24. Longford NT: Reliability of essay rating and score adjustment.
Journal of Educational and Behavioral Statistics 1994, 19(3):171-200.
25. Brennan RL: Generalizability theory New York: Springer; 2001. 
26. McDowell I, Newell C: Measuring Health: a guide to rating scales and
questionnaires 2nd edition. New York: Oxford University Press; 1996. 
27. Broder MS, Oken C, Parker M, Giammona M, Newman J, Harrington
C, et al.: Outpatient Care: A Conceptual Framework and a Form for Struc-
tured Implicit Review Santa Monica, CA: RAND Corporation; 2002. 
28. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Man-
ning WG: The unreliability of individual physician "report
cards" for assessing the costs and quality of care of a chronic
disease. JAMA 1999, 281(22):2098-105.
29. Sixma HJ, Spreeuwenberg PM, van der Pasch MA: Patient satisfac-
tion with the general practitioner: a two-level analysis. Med
Care 1998, 36(2):212-29.
30. Krein SL, Hofer TP, Kerr EA, Hayward RA: Whom should we pro-
file? Examining diabetes care practice variation among pri-
mary care providers, provider groups, and health care
facilities. Health Serv Res 2002, 37(5):1159-80.
31. Casalino LP: The unintended consequences of measuring qual-
ity on the quality of medical care.  N Engl J Med 1999,
341(15):1147-50.
32. Gauging quality regulation's impact on premium costs. Medi-
cine & Health 1997, 51(46):1.
33. Hofer TP, Bernstein SJ, DeMonner S, Hayward RA: Discussion
between reviewers does not improve reliability of peer
review of hospital quality. Med Care 2000, 38(2):152-61.
34. Browne WJ: MCMC Estimation in MLwiN Version 1.0 edition. London:
Centre for Multilevel Modeling, Institute of Education, University of
London; 2002. 
35. Fleiss JL: Statistical Methods for Rates and Proportions 2nd edition. New
York: John Wiley & Sons; 1981:212-36. 
Additional File 1
Implicit Reviewer Recruitment and Selection. A brief description of the 
reviewer recruitment process and a list of the screening questions for the 
reviewer applicants and those listed as clinical references.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-
6963-4-9-S1.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Health Services Research 2004, 4 http://www.biomedcentral.com/1472-6963/4/9
Page 12 of 12
(page number not for citation purposes)
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6963/4/9/prepub